Research on senotherapeutics is exploring various strategies, including broad-spectrum senolysis and precision reprogramming. Studies are investigating different approaches to targeting senescent cells, such as using pharmacological inhibitors, immunotherapies, and specific compounds like nintedanib and cardiac glycosides. These approaches aim to address cellular senescence-related issues, including chemoresistance in certain types of lymphoma.